InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-26.9%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Trudel Gregory J., Chairman & CEO. Officer active across 1 company, notably ENCISION INC. Cumulatively, 6 disclosures have been recorded. Split: 2 buys · 0 sell. Total volume traded: €87k. Activity tracked since 11 August 2021. The latest transaction was filed on 19 August 2025 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
1,000,000 shares@ US$0.10Common StockSEC:0001594965-25-000002:0
Ideal exit: 16 May 2026 (T+270)
5,000 shares@ US$0.351.2% of flowCommon StockSEC:0000930775-24-000009:0
3,300 shares@ US$0.320.7% of flowCommon StockSEC:0000930775-24-000001:0
Ideal exit: 17 May 2025 (T+270)
200,000 shares@ US$0.33543.9% of flowCommon stockSEC:0001555569-24-000005:0
70,000 shares@ US$0.300.55% mcap24.1% of flowcommon stockSEC:0001555569-22-000003:0
75,000 shares@ US$0.310.59% mcap25.9% of flowCommon StockSEC:0001555569-21-000008:0
6 of 6 declarations
About Trudel Gregory J.
Gregory J. Trudel serves as CEO of Encision Inc. As the leader of the company, he is responsible for the overall strategy and operational direction. With extensive experience in the medical sector, he oversees daily operations and guides the company toward sustainable growth and increased profitability.
